These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18711212)

  • 1. Immunocytological and preliminary immunohistochemical studies of prothymosin alpha, a human cancer-associated polypeptide, with a well-characterized polyclonal antibody.
    Klimentzou P; Drougou A; Fehrenbacher B; Schaller M; Voelter W; Barbatis C; Paravatou-Petsotas M; Livaniou E
    J Histochem Cytochem; 2008 Nov; 56(11):1023-31. PubMed ID: 18711212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and immunochemical evaluation of antibodies Y for the poorly immunogenic polypeptide prothymosin alpha.
    Klimentzou P; Paravatou-Petsotas M; Zikos C; Beck A; Skopeliti M; Czarnecki J; Tsitsilonis O; Voelter W; Livaniou E; Evangelatos GP
    Peptides; 2006 Jan; 27(1):183-93. PubMed ID: 16150512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin α(100-109) in sera of mice infected with bacteria.
    Samara P; Kalbacher H; Ioannou K; Radu DL; Livaniou E; Promponas VJ; Voelter W; Tsitsilonis O
    J Immunol Methods; 2013 Sep; 395(1-2):54-62. PubMed ID: 23831611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Immunodetection of Prothymosin Alpha in Normal and Pathological Conditions.
    Karachaliou CE; Kalbacher H; Voelter W; Tsitsilonis OE; Livaniou E
    Curr Med Chem; 2020; 27(29):4840-4854. PubMed ID: 31389310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of prothymosin alpha is related to pituitary adenoma recurrence but not to adenoma invasiveness and proliferation.
    Pawlikowski M; Radek M; Kunert-Radek J; Jaranowska M; Świętosławski J; Winczyk K
    Endokrynol Pol; 2014; 65(5):382-6. PubMed ID: 25301489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional distribution and cell type-specific subcellular localization of Prothymosin alpha in brain.
    Halder SK; Ueda H
    Cell Mol Neurobiol; 2012 Jan; 32(1):59-66. PubMed ID: 21750924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients.
    Skopeliti M; Voutsas IF; Klimentzou P; Tsiatas ML; Beck A; Bamias A; Moraki M; Livaniou E; Neagu M; Voelter W; Tsitsilonis OE
    Cancer Immunol Immunother; 2006 Oct; 55(10):1247-57. PubMed ID: 16453152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prothymosin alpha and tumor: current status and perspective].
    Wang M; Pan JY
    Ai Zheng; 2007 Mar; 26(3):333-6. PubMed ID: 17355803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-induced non-vesicular release of prothymosin-α initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage.
    Matsunaga H; Ueda H
    Cell Death Differ; 2010 Nov; 17(11):1760-72. PubMed ID: 20467443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo biodistribution and imaging studies with a
    Karachaliou CE; Triantis C; Liolios C; Palamaris L; Zikos C; Tsitsilonis OE; Kalbacher H; Voelter W; Loudos G; Papadopoulos M; Pirmettis I; Livaniou E
    Eur J Pharm Biopharm; 2017 Apr; 113():188-197. PubMed ID: 28087377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy.
    Ioannou K; Samara P; Livaniou E; Derhovanessian E; Tsitsilonis OE
    Cancer Immunol Immunother; 2012 May; 61(5):599-614. PubMed ID: 22366887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothymosin Alpha: An Alarmin and More..
    Samara P; Karachaliou CE; Ioannou K; Papaioannou NE; Voutsas IF; Zikos C; Pirmettis I; Papadopoulos M; Kalbacher H; Livaniou E; Tsitsilonis OE; Voelter W
    Curr Med Chem; 2017; 24(17):1747-1760. PubMed ID: 28521686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular dissemination of prothymosin alpha at normal physiology: immunohistochemical vis-a-vis western blotting perspective.
    Kijogi CM; Khayeka-Wandabwa C; Sasaki K; Tanaka Y; Kurosu H; Matsunaga H; Ueda H
    BMC Physiol; 2016 Mar; 16():2. PubMed ID: 26932824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prothyomosin alpha interaction with KEAP1 doesn't lead to prothymosin alpha ubiquination and degradation].
    Mel'nikov SV; Evstaf'eva AG; Vartapetian AB
    Mol Biol (Mosk); 2007; 41(5):868-75. PubMed ID: 18240569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon induces the interaction of prothymosin-alpha with STAT3 and results in the nuclear translocation of the complex.
    Yang CH; Murti A; Baker SJ; Frangou-Lazaridis M; Vartapetian AB; Murti KG; Pfeffer LM
    Exp Cell Res; 2004 Aug; 298(1):197-206. PubMed ID: 15242774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothymosin-α Variants Elicit Anti-HIV-1 Response via TLR4 Dependent and Independent Pathways.
    Gusella GL; Teixeira A; Aberg J; Uversky VN; Mosoian A
    PLoS One; 2016; 11(6):e0156486. PubMed ID: 27310139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothymosin α activates type I collagen to develop a fibrotic placenta in gestational diabetes.
    Wu HT; Kang L; Su YC; Ou HY; Chan FY; Chen YC; Su BH; Wang YS; Wu CL; Shiau AL; Wu P
    Clin Sci (Lond); 2020 Sep; 134(18):2435-2445. PubMed ID: 32909608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothymosin α variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction.
    Teixeira A; Yen B; Gusella GL; Thomas AG; Mullen MP; Aberg J; Chen X; Hoshida Y; van Bakel H; Schadt E; Basler CF; García-Sastre A; Mosoian A
    J Infect Dis; 2015 May; 211(9):1467-75. PubMed ID: 25404520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothymosin α interacts with SET, ANP32A and ANP32B and other cytoplasmic and mitochondrial proteins in proliferating cells.
    Barbeito P; Sarandeses CS; Díaz-Jullien C; Muras J; Covelo G; Moreira D; Freire-Cobo C; Freire M
    Arch Biochem Biophys; 2017 Dec; 635():74-86. PubMed ID: 29106904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.